Jun 18, 2026 07:00AM
Jun 18, 2026 07:00AM
Jun 16, 2026 03:22PM
Jun 16, 2026 10:18AM
Jun 10, 2026 07:30AM
Jun 10, 2026 07:30AM
May 18, 2026 07:30AM CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates
Apr 22, 2026 07:30AM
Apr 7, 2026 07:30AM
Apr 7, 2026 07:30AM
Mar 19, 2026 07:31AM
Mar 19, 2026 07:30AM
Mar 17, 2026 07:30AM
Mar 12, 2026 07:00AM CervoMed Announces Presentations at Upcoming AD/PD™ 2026 Scientific Conference
Mar 4, 2026 07:30AM
Mar 4, 2026 07:30AM
Feb 18, 2026 06:02AM
Feb 18, 2026 06:00AM
Dec 4, 2025 05:00PM
Dec 4, 2025 05:00PM
Dec 2, 2025 07:01AM CervoMed shows biomarker improvements in dementia trial
Dec 2, 2025 07:00AM
Nov 24, 2025 07:00AM
Nov 10, 2025 07:00AM
Nov 4, 2025 07:00AM
Nov 4, 2025 07:00AM
Oct 28, 2025 08:03AM
Oct 28, 2025 08:00AM CervoMed Strengthens Board with Appointment of Life Sciences Business Strategy Leader David Quigley
Oct 8, 2025 07:00AM
Oct 8, 2025 07:00AM
Oct 7, 2025 08:01AM
Oct 7, 2025 08:00AM
Sep 17, 2025 07:30AM
Aug 11, 2025 08:00AM
Jul 28, 2025 07:01AM CervoMed reports positive 32-week trial data for dementia drug
Jul 28, 2025 07:00AM
Jun 10, 2025 08:00AM
May 12, 2025 08:00AM
Apr 2, 2025 07:00AM
Mar 17, 2025 08:00AM
Mar 10, 2025 04:05PM
Nov 12, 2024 07:00AM CervoMed Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
Sep 18, 2024 05:17AM
Aug 12, 2024 08:00AM
May 15, 2024 08:00AM
Apr 1, 2024 08:00AM
Nov 13, 2023 07:00AM
Oct 25, 2023 02:50PM
Oct 24, 2023 07:00AM CervoMed Announces Publications in Major Peer-Reviewed Journals That Inform on Potential of Neflamapimod as a Disease-Modifying Therapy for the Major Dementias
Oct 18, 2023 07:00AM

1,160,146 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All